Clinical Trials

160 enrolled

Pathologic Complete Response, Lymphoma, T-Cell, Peripheral

NCT07253129 2025-12-23

T-START-PR

88 enrolled

Lymphoma, T-Cell, Peripheral

NCT06422247 2025-06-04

Observational Study in Japanese Patients With Peripheral T-Cell Lymphoma Who Received Second-Line Therapy

307 enrolled

Lymphoma, T-Cell, Peripheral

NCT06963632 2025-05-09

JOYCE

Not yet recruiting

1,000 enrolled

Lymphoma, T-Cell, Peripheral

NCT03964480 2025-05-06

Prospective Observational International Registry of Patients With Newly Diagnosed Peripheral T Cell Lymphoma.

1,000 enrolled

Lymphoma, T-Cell, Peripheral, Rare Diseases

NCT04213209 2024-09-27

Special Drug Use Surveillance for Brentuximab Vedotin Intravenous Infusion "Relapsed or Refractory CD30-positive Peripheral T Cell Lymphoma or Pediatric Hodgkin Lymphoma"

95 enrolled 30 charts

Lymphoma, T-Cell, Peripheral

NCT03297697 2024-05-16

Minimal Residual Disease in Peripheral T-cell Lymphoma

44 enrolled

Lymphoma, T-Cell, Peripheral

NCT05934864 2024-05-16

Different Molecular Subtypes of Peripheral T-cell Lymphoma, a Real-world Registry Study. (TRUST)

1,000 enrolled

Lymphoma, T-Cell, Peripheral

NCT04858568 2024-02-06

PROSECO

LymphoidOther hematologic neoplasm

592 enrolled

Burkitt Lymphoma, Hodgkin Disease, Lymphoma, Follicular, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Peripheral, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT05137847 2023-12-12

A Study of Remitoro in Participants With Recurrent or Refractory Peripheral T Cell Lymphoma and Cutaneous T Cell Lymphoma (All Case Study)

118 enrolled

DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Drug-Related Side Effects and Adverse Reactions

NCT03742921 2023-12-06

ISTODAX® for Intravenous Infusion Drug Use Results Survey- Relapsed or Refractory Peripheral T-Cell Lymphoma

150 enrolled

LymphoidOther hematologic neoplasm

Recurrence, Lymphoma, T-Cell, Peripheral

NCT05923502 2023-10-23

(CHANT)Real World Study of Duvelisib in the Treatment of Non-Hodgkin's Lymphoma (NHL)

Not yet recruiting

200 enrolled

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Peripheral, Lymphoma, B-Cell, Marginal Zone

NCT04489264 2020-12-04

The Role of Consolidative Autologous Stem Cell Transplantation After First-line Therapy in Peripheral T Cell Lymphoma

60 enrolled

Lymphoma, T-Cell, Peripheral

NCT01110733 2020-01-13

COMPLETE

3,000 enrolled

Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, T-Cell, Peripheral

NCT01142674 2019-07-08

T-Cell Project: Prospective Collection of Data in Patients With Peripheral T-Cell Lymphoma

1,650 enrolled

Lymphoma, T-Cell, Peripheral, Rare Diseases

NCT03356678 2017-11-29

Pralatrexate for Relapsed or Refractory Peripheral T-cell Lymphoma

33 enrolled

Recurrence, Lymphoma, T-Cell, Peripheral

NCT00705809 2017-07-02

T-Cell Project: Epidemiologic Component

800 enrolled

Lymphoma, T-Cell, Peripheral

NCT01390597 2017-05-17

Biomarkers in Tumor Tissue Samples From Patients With Peripheral T-cell Lymphoma or Natural Killer Cell Neoplasms

LymphoidOther hematologic neoplasm

32 enrolled

Lymphoma, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT03000738 2017-03-31

The Value and Mechanisms for Monocytes Subpopulations in Predicting the Prognosis of Lymphomas

100 enrolled

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Peripheral

NCT03079947 2017-03-27

Effectiveness of Circulating DNA for Predicting the Relapse and Overall Survival in NHL Patients

300 enrolled

Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Peripheral

NCT02788916 2017-03-21

A Retrospective Study of Clinical, Phenotypic and Genetic Factors of Peripheral T-Cell Lymphomas

198 enrolled

Lymphoma, T-Cell, Peripheral

NCT02364466 2015-02-18

Cohort of Peripheral T Cell Lymphoma

Classical hematologyLymphoid

200 enrolled

Lymphoma, T-Cell, Peripheral, Febrile Neutropenia

NCT01470066 2011-11-11

Clinical Usefulness and Prognostic Significance of Interim 18F-FDG PET/CT for the Treatment of Peripheral T Cell Lymphomas

80 enrolled